Federal Jurisdiction: U.S. v. Tohono O'odham Nation
Gene Patents: Ass’n for Molecular Pathology v. USPTO (Myriad Genetics)
Guantanamo: Boumediene v. Bush
Intellectual Property: Board of Trustees of the Leland Stanford Jr. University v. Roche Molecular Systems, Inc.
Patent Law: Microsoft v. i4i Limited Partnership
Patent Obviousness: KSR v. Teleflex
Patent Reform
Patentable Subject Matter: In re Bilski
Aviation
Capital Markets
Cleantech and Energy
Education
Financial Services
FinTech
Insurance
Life Sciences
Manufacturing
Media and Entertainment
Nanotechnology
National Security: Defense and Intelligence
Pharmaceutical and Health Care
Professional Services
Real Estate
Securities
Subprime Market
Telecommunications
Venture Capital
United States Patent Office Publishes New Rules on Continuing Applications and Claims
On August 21, 2007, the US Patent and Trademark Office published revised rules that make a number of controversial revisions relating to patent prosecution. Two key aspects of the revised rules involve limitations on the number of continuation applications and the number of claims in an application. In particular, the revised rules provide that an applicant seeking to file more than two continuation or continuation-in-part applications, or more than one request for continued examination, must present a showing as to why an amendment, argument or evidence sought to be entered could not have been previously submitted. The revised rules also require an applicant to file an examination support document covering all of the claims in any application containing more than five independent claims or 25 total claims. Revised rules also were published regarding multiple applications having the same filing or priority date, substantial overlapping disclosure, a common inventor and common ownership.
WilmerHale CommentaryPTO ResourcesLitigation ResourcesParties' BriefsAmicus Briefs Supporting GSK/TafasAmicus Briefs Supporting PTO
WilmerHale Commentary
PTO Resources
Litigation Resources
Parties' Briefs - Federal Circuit
Parties' Briefs - District Court
Amicus Briefs Supporting GSK/Tafas - Federal Circuit
Amicus Briefs Supporting GSK/Tafas - District Court
Amicus Briefs Supporting PTO - Federal Circuit
Amicus Briefs Supporting PTO - District Court